News & Media
Careers
Contact Us
""

Home
About Us
BUSINESSES
Foundation
Investors

News & Media Careers Contact Us

Home
About Us
Business
Foundation
investor
- Piramal Enterprises Ltd
- Piramal Pharma Ltd

Privacy Policy
Disclaimer
© 2022 Piramal Enterprises Ltd.

Financial
Reports
Corporate
Governance
Shareholder
Information
Investor
Contacts
E-Auction
PEL Investor Day

Shareholder Information
& Services

Investors
Piramal Enterprises Limited
Shareholder Information
Postal Ballot

Postal Ballot

Shareholding
Pattern
Notice
Share
Capital
Dividend
Unclaimed
Dividend
Credit
Rating
PPMLD
Valuation
Forms
Announcements
Statement of
Employees
ESOP
Disclosure
Scheme of
Amalgamation
Composite Scheme
of Arrangement
Rights
Issue
Postal
Ballot
Buyback
2023
NCD Public
Issuance 2023
Online Dispute Resolution (ODR)

PEL – Scrutinizer’s Report for Postal Ballot – 13th December 2022
Postal Ballot Notice - November 2022
PEL – Scrutinizer’s Report for Postal Ballot - 2022
PEL - Postal Ballot Notice - 2022

Investor Presentation

PEL Investor Presentation – Q4 FY2023

Quick Links

Annual Report – 2022-23

Investor Calls
Buyback – 2023

Investor Contacts
Press Releases
In The News

Piramal Group

Piramal Enterprises Ltd.(PEL)
Piramal Pharma Ltd.(PPL)
Piramal Realty
Piramal Foundation

Piramal Enterprises Ltd.

Financial Services
– Piramal Capital & Housing Finance Limited (PCHFL)
– Piramal Alternatives (PA)

Piramal Pharma Ltd.

Piramal Pharma Ltd.
– Pharma Solutions
– Critical Care
– Consumer Products
– Allergan India Private Limited

Piramal Realty

– Piramal Mahalaxmi
– Piramal Aranya
– Piramal Revanta
– Piramal Vaikunth
– Piramal Agastya

© 2024 Piramal Enterprises Ltd.

Privacy Policy
Disclaimer